Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 73, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'catslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]Code Context
trigger_error($message, E_USER_DEPRECATED);
}
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.' $stackFrame = (int) 1 $trace = [ (int) 0 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php', 'line' => (int) 2421, 'function' => 'deprecationWarning', 'args' => [ (int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.' ] ], (int) 1 => [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) {}, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ], (int) 2 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php', 'line' => (int) 610, 'function' => 'printArticle', 'class' => 'App\Controller\ArtileDetailController', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 3 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 120, 'function' => 'invokeAction', 'class' => 'Cake\Controller\Controller', 'object' => object(App\Controller\ArtileDetailController) {}, 'type' => '->', 'args' => [] ], (int) 4 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php', 'line' => (int) 94, 'function' => '_invoke', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(App\Controller\ArtileDetailController) {} ] ], (int) 5 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php', 'line' => (int) 235, 'function' => 'dispatch', 'class' => 'Cake\Http\ActionDispatcher', 'object' => object(Cake\Http\ActionDispatcher) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 6 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Http\BaseApplication', 'object' => object(App\Application) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 7 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php', 'line' => (int) 162, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 8 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\RoutingMiddleware', 'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 9 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php', 'line' => (int) 88, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 10 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Routing\Middleware\AssetMiddleware', 'object' => object(Cake\Routing\Middleware\AssetMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 11 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php', 'line' => (int) 96, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 12 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 65, 'function' => '__invoke', 'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware', 'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {}, (int) 2 => object(Cake\Http\Runner) {} ] ], (int) 13 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php', 'line' => (int) 51, 'function' => '__invoke', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\ServerRequest) {}, (int) 1 => object(Cake\Http\Response) {} ] ], (int) 14 => [ 'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php', 'line' => (int) 98, 'function' => 'run', 'class' => 'Cake\Http\Runner', 'object' => object(Cake\Http\Runner) {}, 'type' => '->', 'args' => [ (int) 0 => object(Cake\Http\MiddlewareQueue) {}, (int) 1 => object(Cake\Http\ServerRequest) {}, (int) 2 => object(Cake\Http\Response) {} ] ], (int) 15 => [ 'file' => '/home/brlfuser/public_html/webroot/index.php', 'line' => (int) 39, 'function' => 'run', 'class' => 'Cake\Http\Server', 'object' => object(Cake\Http\Server) {}, 'type' => '->', 'args' => [] ] ] $frame = [ 'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php', 'line' => (int) 74, 'function' => 'offsetGet', 'class' => 'Cake\Http\ServerRequest', 'object' => object(Cake\Http\ServerRequest) { trustProxy => false [protected] params => [ [maximum depth reached] ] [protected] data => [[maximum depth reached]] [protected] query => [[maximum depth reached]] [protected] cookies => [[maximum depth reached]] [protected] _environment => [ [maximum depth reached] ] [protected] url => 'latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222/print' [protected] base => '' [protected] webroot => '/' [protected] here => '/latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222/print' [protected] trustedProxies => [[maximum depth reached]] [protected] _input => null [protected] _detectors => [ [maximum depth reached] ] [protected] _detectorCache => [ [maximum depth reached] ] [protected] stream => object(Zend\Diactoros\PhpInputStream) {} [protected] uri => object(Zend\Diactoros\Uri) {} [protected] session => object(Cake\Http\Session) {} [protected] attributes => [[maximum depth reached]] [protected] emulatedAttributes => [ [maximum depth reached] ] [protected] uploadedFiles => [[maximum depth reached]] [protected] protocol => null [protected] requestTarget => null [private] deprecatedProperties => [ [maximum depth reached] ] }, 'type' => '->', 'args' => [ (int) 0 => 'artileslug' ] ]deprecationWarning - CORE/src/Core/functions.php, line 311 Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421 App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74 Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51 Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98
Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]Code Contextif (Configure::read('debug')) {
trigger_error($message, E_USER_WARNING);
} else {
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-trace').style.display = (document.getElementById('cakeErr67fe7698582b3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7698582b3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-code').style.display = (document.getElementById('cakeErr67fe7698582b3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-context').style.display = (document.getElementById('cakeErr67fe7698582b3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7698582b3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67fe7698582b3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 3135, 'metaTitle' => 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...', 'disp' => '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 3135 $metaTitle = 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs' $metaKeywords = 'Health' $metaDesc = ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...' $disp = '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs | Im4change.org</title> <meta name="description" content=" Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Foreign bias finger at PMO on cheap drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font></p><p align="justify"><font >The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $maxBufferLength = (int) 8192 $file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php' $line = (int) 853 $message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]Code Context$response->getStatusCode(),
($reasonPhrase ? ' ' . $reasonPhrase : '')
));
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-trace').style.display = (document.getElementById('cakeErr67fe7698582b3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7698582b3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-code').style.display = (document.getElementById('cakeErr67fe7698582b3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-context').style.display = (document.getElementById('cakeErr67fe7698582b3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7698582b3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67fe7698582b3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 3135, 'metaTitle' => 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...', 'disp' => '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 3135 $metaTitle = 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs' $metaKeywords = 'Health' $metaDesc = ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...' $disp = '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs | Im4change.org</title> <meta name="description" content=" Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Foreign bias finger at PMO on cheap drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font></p><p align="justify"><font >The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $reasonPhrase = 'OK'header - [internal], line ?? Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]Notice (8): Undefined variable: urlPrefix [APP/Template/Layout/printlayout.ctp, line 8]Code Context$value
), $first);
$first = false;
$response = object(Cake\Http\Response) { 'status' => (int) 200, 'contentType' => 'text/html', 'headers' => [ 'Content-Type' => [ [maximum depth reached] ] ], 'file' => null, 'fileRange' => [], 'cookies' => object(Cake\Http\Cookie\CookieCollection) {}, 'cacheDirectives' => [], 'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> <html xmlns="http://www.w3.org/1999/xhtml"> <head> <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-trace').style.display = (document.getElementById('cakeErr67fe7698582b3-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67fe7698582b3-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-code').style.display = (document.getElementById('cakeErr67fe7698582b3-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67fe7698582b3-context').style.display = (document.getElementById('cakeErr67fe7698582b3-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67fe7698582b3-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700"><</span><span style="color: #0000BB">head</span><span style="color: #007700">> </span></span></code> <span class="code-highlight"><code><span style="color: #000000"> <link rel="canonical" href="<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">); </span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">category</span><span style="color: #007700">-></span><span style="color: #0000BB">slug</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>/<span style="color: #0000BB"><?php </span><span style="color: #007700">echo </span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-></span><span style="color: #0000BB">seo_url</span><span style="color: #007700">; </span><span style="color: #0000BB">?></span>.html"/> </span></code></span> <code><span style="color: #000000"><span style="color: #0000BB"> </span><span style="color: #007700"><</span><span style="color: #0000BB">meta http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type" </span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html; charset=utf-8"</span><span style="color: #007700">/> </span></span></code></pre><pre id="cakeErr67fe7698582b3-context" class="cake-context" style="display: none;">$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 3135, 'metaTitle' => 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...', 'disp' => '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 3135 $metaTitle = 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs' $metaKeywords = 'Health' $metaDesc = ' Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...' $disp = '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister&rsquo;s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. &ldquo;We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,&rdquo; the NGOs wrote.</font></p><p align="justify"><font >The NGOs &mdash; the All India Drug Action Network, the People&rsquo;s Health Movement, the Naz Foundation, among others &mdash; have expressed concern at what they describe is increasing government susceptibility to &ldquo;non-transparent lobbying&rdquo; by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India&rsquo;s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >&ldquo;We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,&rdquo; the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >&ldquo;This is an issue that concerns patients in India and other developing countries,&rdquo; said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/foreign-bias-finger-at-pmo-on-cheap-drugs-3222.html"/> <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css" media="all"/> <title>LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs | Im4change.org</title> <meta name="description" content=" Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,..."/> <script src="https://im4change.in/js/jquery-1.10.2.js"></script> <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script> <script language="javascript" type="text/javascript"> $(document).ready(function () { var img = $("img")[0]; // Get my img elem var pic_real_width, pic_real_height; $("<img/>") // Make in memory copy of image to avoid css issues .attr("src", $(img).attr("src")) .load(function () { pic_real_width = this.width; // Note: $(this).width() will not pic_real_height = this.height; // work for in memory images. }); }); </script> <style type="text/css"> @media screen { div.divFooter { display: block; } } @media print { .printbutton { display: none !important; } } </style> </head> <body> <table cellpadding="0" cellspacing="0" border="0" width="98%" align="center"> <tr> <td class="top_bg"> <div class="divFooter"> <img src="https://im4change.in/images/logo1.jpg" height="59" border="0" alt="Resource centre on India's rural distress" style="padding-top:14px;"/> </div> </td> </tr> <tr> <td id="topspace"> </td> </tr> <tr id="topspace"> <td> </td> </tr> <tr> <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> <tr> <td width="100%"> <h1 class="news_headlines" style="font-style:normal"> <strong>Foreign bias finger at PMO on cheap drugs</strong></h1> </td> </tr> <tr> <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3"> <p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font></p><p align="justify"><font >The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p> </font> </td> </tr> <tr> <td> </td> </tr> <tr> <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;"> <form><input type="button" value=" Print this page " onclick="window.print();return false;"/></form> </td> </tr> </table></body> </html>' } $cookies = [] $values = [ (int) 0 => 'text/html; charset=UTF-8' ] $name = 'Content-Type' $first = true $value = 'text/html; charset=UTF-8'header - [internal], line ?? Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181 Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55 Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141 [main] - ROOT/webroot/index.php, line 39
<head>
<link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp' $dataForView = [ 'article_current' => object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ [maximum depth reached] ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ [maximum depth reached] ], '[dirty]' => [[maximum depth reached]], '[original]' => [[maximum depth reached]], '[virtual]' => [[maximum depth reached]], '[hasErrors]' => false, '[errors]' => [[maximum depth reached]], '[invalid]' => [[maximum depth reached]], '[repository]' => 'Articles' }, 'articleid' => (int) 3135, 'metaTitle' => 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs', 'metaKeywords' => 'Health', 'metaDesc' => ' Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...', 'disp' => '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font></p><p align="justify"><font >The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>', 'lang' => 'English', 'SITE_URL' => 'https://im4change.in/', 'site_title' => 'im4change', 'adminprix' => 'admin' ] $article_current = object(App\Model\Entity\Article) { 'id' => (int) 3135, 'title' => 'Foreign bias finger at PMO on cheap drugs', 'subheading' => '', 'description' => '<p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p> <p align="justify"> <br /> <font face="arial,helvetica,sans-serif" size="3">Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3">“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font> </p> <p align="justify"> <font face="arial,helvetica,sans-serif" size="3"></font> </p>', 'credit_writer' => 'The Telegraph, 8 September, 2010, http://www.telegraphindia.com/1100908/jsp/nation/story_12910623.jsp', 'article_img' => '', 'article_img_thumb' => '', 'status' => (int) 1, 'show_on_home' => (int) 1, 'lang' => 'EN', 'category_id' => (int) 16, 'tag_keyword' => '', 'seo_url' => 'foreign-bias-finger-at-pmo-on-cheap-drugs-3222', 'meta_title' => null, 'meta_keywords' => null, 'meta_description' => null, 'noindex' => (int) 0, 'publish_date' => object(Cake\I18n\FrozenDate) {}, 'most_visit_section_id' => null, 'article_big_img' => null, 'liveid' => (int) 3222, 'created' => object(Cake\I18n\FrozenTime) {}, 'modified' => object(Cake\I18n\FrozenTime) {}, 'edate' => '', 'tags' => [ (int) 0 => object(Cake\ORM\Entity) {} ], 'category' => object(App\Model\Entity\Category) {}, '[new]' => false, '[accessible]' => [ '*' => true, 'id' => false ], '[dirty]' => [], '[original]' => [], '[virtual]' => [], '[hasErrors]' => false, '[errors]' => [], '[invalid]' => [], '[repository]' => 'Articles' } $articleid = (int) 3135 $metaTitle = 'LATEST NEWS UPDATES | Foreign bias finger at PMO on cheap drugs' $metaKeywords = 'Health' $metaDesc = ' Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said. In a joint letter to Prime Minister Manmohan Singh,...' $disp = '<p align="justify"><font ></font></p><p align="justify"><br /><font >Multinational drug companies appear to have used the Prime Minister’s Office to try and influence government policies that may severely undermine availability of affordable medicines, a group of non-government organisations has said.</font></p><p align="justify"><font >In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies.</font></p><p align="justify"><font >They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies.</font></p><p align="justify"><font >One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said.</font></p><p align="justify"><font >This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote.</font></p><p align="justify"><font >The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies.</font></p><p align="justify"><font >Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year.</font></p><p align="justify"><font >In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO.</font></p><p align="justify"><font >In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department.</font></p><p align="justify"><font >A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment.</font></p><p align="justify"><font >The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines.</font></p><p align="justify"><font >“We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies.</font></p><p align="justify"><font >“This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers.</font></p><p align="justify"><font ></font></p>' $lang = 'English' $SITE_URL = 'https://im4change.in/' $site_title = 'im4change' $adminprix = 'admin'
include - APP/Template/Layout/printlayout.ctp, line 8 Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413 Cake\View\View::_render() - CORE/src/View/View.php, line 1374 Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927 Cake\View\View::render() - CORE/src/View/View.php, line 885 Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791 Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126 Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94 Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96 Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65 Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
![]() |
Foreign bias finger at PMO on cheap drugs |
In a joint letter to Prime Minister Manmohan Singh, 50 NGOs said the PMO had asked the ministry of health and the departments of legal affairs and industrial policy to examine intellectual property rights issues raised by foreign pharmaceutical companies. They said the PMO had in July circulated to these departments two notes on data protection and amendment to patent laws submitted by the Organisation of Pharmaceutical Producers of India (OPPI), an association of foreign companies. One of the notes seeks data exclusivity, a provision under drug laws that could effectively block generic versions of medicines from entering the market by creating a monopoly over clinical trials data, the NGOs have said. This demand for data exclusivity is contrary to the Indian Constitution and Indian laws, they said. “We regret that the PMO circulated this biased note without prior investigation into the legitimacy of the claims or the fact that several demands made by the OPPI, US and European pharmaceutical companies are either sub judice or have been rejected by Indian courts,” the NGOs wrote. The NGOs — the All India Drug Action Network, the People’s Health Movement, the Naz Foundation, among others — have expressed concern at what they describe is increasing government susceptibility to “non-transparent lobbying” by multinational drug companies. Documents released by the NGOs suggest that the heads of five multinational pharmaceutical companies, including Ranjit Shahani, managing director, Novartis, and president of the OPPI, met PMO officials on May 24 this year. In the discussions, according to the documents, it was agreed the OPPI would prepare a paper on enforcement of intellectual property rights, data protection and capacity building of the judiciary, highlighting the steps required and submit it to the PMO. In July, the PMO sent two notes submitted by the OPPI to the ministry of health and the departments of industrial policy and legal affairs to examine these issues and give their comments to the pharmaceuticals department. A final paper to be co-ordinated by the pharmaceuticals department is expected to be put up to the PMO. The PMO officials who attended the meeting were not available for comment. The NGOs have said the OPPI demands could weaken provisions in India’s patent laws that prohibit patents on minor tweaking of existing drug molecules, prevent the emergence of generic medicines, and undermine access to affordable medicines. “We are also extremely concerned that there are indications that the OPPI is also attempting to influence the training of judges,” the NGOs have said. Indian courts have in the past upheld sections of Indian patent law challenged by foreign drug companies. “This is an issue that concerns patients in India and other developing countries,” said Leena Menghaney, a lawyer who works with the Medicins Sans Frontiers. |